SCHEMBL2925587

SCHEMBL2925587

FC(F)(F)c1cccc(NNc2cccc(C(F)(F)F)c2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.58
ALDH1A1 P00352 4/20 0.58
GAA P10253 2/20 0.58
NPSR1 Q6W5P4 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
RAB9A P51151 2/20 0.56
IDH2 P48735 2/20 0.56
HTT P42858 1/20 0.56
SMN1; SMN2 Q16637 3/20 0.55
RAPGEF4 Q8WZA2 1/20 0.55
IDO1 P14902 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
KIF11 P52732 1/20 0.55
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
MMP2 P08253 1/20 0.53
TP53 P04637 1/20 0.53
TSHR P16473 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29748950 1.00 MAPT (0.58) MAPTALDH1A1GAANPSR1TDP1
SCHEMBL4093215 0.92 MAPT (0.51) MAPTALDH1A1GAANPSR1TDP1
SCHEMBL20320380 0.87 IDH2 (0.57) MAPTALDH1A1GAANPSR1TDP1
SCHEMBL5508209 0.87 MAPT (0.51) MAPTALDH1A1GAANPSR1TDP1
SCHEMBL394991 0.86 KIF11 (0.70) MAPTALDH1A1GAANPSR1TDP1
Hydrochloric Acid SCHEMBL28200105 0.86 MAPT (0.50) MAPTALDH1A1GAANPSR1TDP1
Hydrochloric Acid SCHEMBL3601015 0.86 MAPT (0.50) MAPTALDH1A1GAANPSR1TDP1
SCHEMBL10985182 0.85 MAPT (0.70) MAPTALDH1A1GAANPSR1TDP1
SCHEMBL5261069 0.84 MAPT (0.56) MAPTALDH1A1GAANPSR1TDP1
SCHEMBL4088560 0.84 MAPT (0.54) MAPTALDH1A1GAANPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7772436-B2 Process for producing 2,2′-bis(trifluoromethyl)-4,4′-diaminobiphenyl AIR WATER INC. (JP) 2010-08-10 US claimed
EP-1816118-B1 PROCESS FOR PRODUCING 2,2'-BIS(TRIFLUOROMETHYL)-4,4'-DIAMINOBIPHENYL AIR WATER INC (JP) 2010-01-27 EP claimed
US-20090069602-A1 Process for Producing 2,2'-Bis(Trifluoromethyl)-4,4'-Diaminobiphenyl AIR WATER INC. (JP) 2009-03-12 US claimed
EP-1816118-A1 PROCESS FOR PRODUCING 2,2'-BIS(TRIFLUOROMETHYL)-4,4'-DIAMINOBIPHENYL Air Water Inc. (JP) 2007-08-08 EP claimed
US-20220402858-A1 METHOD FOR PREPARING DIAMINOBIPHENYL COMPOUND SEIKA CORPORATION (JP) 2022-12-22 US disclosed
US-20220402858-A1 METHOD FOR PREPARING DIAMINOBIPHENYL COMPOUND SEIKA CORPORATION (JP) 2022-12-22 US disclosed
WO-2021131549-A1 METHOD FOR PRODUCING DIAMINOBIPHENYL COMPOUND セイカ株式会社 2021-07-01 WO disclosed
WO-2021131549-A1 METHOD FOR PRODUCING DIAMINOBIPHENYL COMPOUND セイカ株式会社 2021-07-01 WO disclosed
US-7772436-B2 Process for producing 2,2′-bis(trifluoromethyl)-4,4′-diaminobiphenyl AIR WATER INC. (JP) 2010-08-10 US disclosed
US-7772436-B2 Process for producing 2,2′-bis(trifluoromethyl)-4,4′-diaminobiphenyl AIR WATER INC. (JP) 2010-08-10 US disclosed
EP-1816118-B1 PROCESS FOR PRODUCING 2,2'-BIS(TRIFLUOROMETHYL)-4,4'-DIAMINOBIPHENYL AIR WATER INC (JP) 2010-01-27 EP disclosed
US-20090069602-A1 Process for Producing 2,2'-Bis(Trifluoromethyl)-4,4'-Diaminobiphenyl AIR WATER INC. (JP) 2009-03-12 US disclosed
EP-1816118-A1 PROCESS FOR PRODUCING 2,2'-BIS(TRIFLUOROMETHYL)-4,4'-DIAMINOBIPHENYL Air Water Inc. (JP) 2007-08-08 EP disclosed
EP-1816118-A1 PROCESS FOR PRODUCING 2,2'-BIS(TRIFLUOROMETHYL)-4,4'-DIAMINOBIPHENYL Air Water Inc. (JP) 2007-08-08 EP disclosed
JP-2006265129-A METHOD FOR PRODUCING 3,3'-BIS(TRIFLUOROMETHYL)HYDRAZOBENZENE AIR WATER INC 2006-10-05 JP disclosed
JP-2006143703-A PRODUCTION METHOD OF 2,2'-BIS(TRIFLUOROMETHYL)-4,4'-DIAMINOBIPHENYL AIR WATER CHEMICAL INC 2006-06-08 JP disclosed
WO-2006048935-A1 PROCESS FOR PRODUCING 2,2'-BIS(TRIFLUOROMETHYL)-4,4'-DIAMINOBIPHENYL AIR WATER INC. (JP) 2006-05-11 WO disclosed
US-5652239-A TREATMENT OF STROKES, ISCHEMIC ATTACK, ANTAGONISTS OF EXCITATORY AMINO ACIDS GLUTAMATE AND ASPARTATE IMPERIAL CHEMICAL COMPANY (GB) 1997-07-29 US disclosed
EP-0512817-B1 Pyridazinedione derivatives, their preparation and pharmaceutical applications ZENECA LTD (GB) 1997-02-19 EP disclosed
EP-0512817-A1 Pyridazinedione derivatives, their preparation and pharmaceutical applications ZENECA LIMITED (GB) 1992-11-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402858-A1 METHOD FOR PREPARING DIAMINOBIPHENYL COMPOUND TERT, NT5C, DDC MAPT 3209/4885ALDH1A1 1868/4885GAA 3266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.